Sun Pharma Receives FDA OK to Make Generic Uroxatral

The FDA has approved Sun Pharmaceutical’s ANDA for a generic version of Sanofi’s prostate treatment Uroxatral XR, giving Sun 180 days of marketing exclusivity as the first filer.
Generic Line